Obesity care, GLP-1s and the new equation for plan sponsors GLP-1s are transforming obesity care, and the decisions plan sponsors make will impact their organizations for years to come Daniel Cusator , MD, MBA, Account Medical Director, Blue Cross Blue Shield of Tennessee Shane Lipp , Senior Benefits Manager, Synovus Claire Morrow , PT, DPT, OCS, FAAOMPT, Physical Therapy Consultant Senior Manager, Hinge Health Charlie Smith , MD, Chief Medical Officer, AON Gabrielle Boisvert , Head of Solution Strategy, Teladoc Health (Moderator) In 2021, it was the beginning of the widespread, mainstream use of GLP-1s for weight loss
doi: 10.1053/j.gastro.2004.04.063 27 SmitsMMTonneijckLMuskietMHAKramerMHHCahenDLvan RaalteDH
If fewer than five days have passed since your missed dose, you should administer the injection as soon as you remember
Designed for Active LifestylesFormulated to meet the increased nutritional demands of athletes, sports enthusiasts, and men with high physical activity levels
What are the potential side effects from Semaglutide w/niacinimide and Tirzepatide w/niacinimide